Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Lögers is active.

Publication


Featured researches published by Michael Lögers.


Angewandte Chemie | 1999

Stereoselective Mukaiyama-Michael/Michael/Aldol Domino Cyclization as the Key Step in the Synthesis of Pentasubstituted Arenes: An Efficient Access to Highly Active Inhibitors of Cholesteryl Ester Transfer Protein (CETP).

Holger Paulsen; Stefan Antons; Arndt Brandes; Michael Lögers; Stephan Nicholas Müller; Paul Naab; Carsten Schmeck; Stephan Schneider; Jürgen Stoltefuß

Seemingly heartbreaking for a stereochemist, the one-step selective construction of a stereopentad and its prompt destruction by aromatization has been proven to be an efficient strategy for the synthesis of fivefold substituted, pharmacologically highly active arenes (see scheme).


Angewandte Chemie | 1999

Stereoselektive Mukaiyama-Michael/Michael/Aldol-Dominocyclisierung als Schlüsselschritt der Synthese pentasubstituierter Arene – ein effizienter Zugang zu hochwirksamen Inhibitoren des Cholesterinester-Transferproteins (CETP)

Holger Paulsen; Stefan Antons; Arndt Brandes; Michael Lögers; Stephan Nicholas Müller; Paul Naab; Carsten Schmeck; Stephan Schneider; Jürgen Stoltefuß

Was das Herz des Stereochemikers bluten last, der einstufige, selektive Aufbau einer Stereopentade und deren prompte Vernichtung durch Aromatisierung, erweist sich als effiziente Strategie zur Synthese funffach substituierter, pharmakologisch hochaktiver Arene (siehe Schema).


Archive | 1997

Cycloalkano-pyridine as CETP inhibitors

Rolf Angerbauer; Hilmar Bischoff; Arndt Brandes; Klaus-Dieter Bremm; Michael Conrad; Henry Giera; Michael Lögers; Matthias Dr. Müller-Gliemann; Paul Naab; Holger Paulsen; Carsten Schmeck; Delf Schmidt; Gunter Schmidt; Joachim Schuhmacher; Jurgen Stoltefuss


Archive | 1997

Heterocyclic condensed pyridines as CETP inhibitors

Rolf Angerbauer; Hilmar Bischoff; Arndt Brandes; Klaus-Dieter Bremm; Michael Lögers; Matthias Dr. Müller-Gliemann; Carsten Schmeck; Delf Schmidt; Gunther Schmidt; Joachim Schuhmacher


Archive | 1997

2-Aryl substituted pyridines

Gunter Schmidt; Rolf Angerbauer; Arndt Brandes; Michael Lögers; Matthias Dr. Müller-Gliemann; Hilmar Bischoff; Delf Schmidt; Stefan Wohlfeil


Archive | 1998

4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein

Jurgen Stoltefuss; Michael Lögers; Gunter Schmidt; Arndt Brandes; Carsten Schmeck; Klaus Dieter Bremm; Hilmar Bischoff; Delf Schmidt


Archive | 1997

Heterocyclic-fused pyridines

Carsten Schmeck; Matthias Dr. Müller-Gliemann; Gunter Schmidt; Arndt Brandes; Rolf Angerbauer; Michael Lögers; Klaus-Dieter Bremm; Hilmar Bischoff; Delf Schmidt; Joachim Schuhmacher


Archive | 1998

5-oxysubstituted chinolines and their use as cholesterol ester transfer proteins inhibitors

Matthias Dr. Müller-Gliemann; Rolf Angerbauer; Arndt Brandes; Michael Lögers; Carsten Schmeck; Gunter Schmidt; Klaus-Dieter Bremm; Hilmar Bischoff; Delf Schmidt


Archive | 1998

4-phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein

Gunter Schmidt; Jurgen Stoltefuss; Michael Lögers; Arndt Brandes; Carsten Schmeck; Klaus-Dieter Bremm; Hilmar Bischoff; Delf Schmidt


Archive | 1998

Tetrahydroquinolines, processes for their preparation, pharmaceutical compositions containing them, and their use to prevent or treat hyperlipoproteinaemia

Gunter Schmidt; Jurgen Stoltefuss; Michael Lögers; Arndt Brandes; Carsten Schmeck; Klaus-Dieter Bremm; Hilmar Bischoff; Delf Schmidt

Researchain Logo
Decentralizing Knowledge